Patents by Inventor Jai Karan

Jai Karan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000348
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Application
    Filed: September 18, 2023
    Publication date: January 4, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
  • Patent number: 11793427
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 24, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Patent number: 11627898
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: April 18, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Publication number: 20220409102
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Application
    Filed: September 2, 2022
    Publication date: December 29, 2022
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Patent number: 11534089
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Grant
    Filed: December 21, 2021
    Date of Patent: December 27, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Publication number: 20220110551
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Publication number: 20200221983
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 16, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Patent number: 10595756
    Abstract: Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: March 24, 2020
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Publication number: 20190192071
    Abstract: Methods, devices, and kits are provided for determining a recommended insulin dose to be administered to user based upon analyte data determined by an analyte sensor.
    Type: Application
    Filed: February 15, 2019
    Publication date: June 27, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc Barry Taub, Erwin Satrya Budiman, Jai Karan, Timothy Christian Dunn
  • Publication number: 20190183393
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Application
    Filed: October 30, 2018
    Publication date: June 20, 2019
    Inventors: Marc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Patent number: 10136845
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 27, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Marc Barry Taub, Jai Karan, Annie C. Tan, Timothy Christian Dunn, Joel Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
  • Publication number: 20180303389
    Abstract: Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.
    Type: Application
    Filed: May 25, 2018
    Publication date: October 25, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, Frederic Arbogast, Jean-Pierre Cole, Namvar Kiaie, Jonathan Fern, Lynne K. Lyons, William J. Matievich, JR., Lynn Dixon, Mark P. Jesser, Matthew T. Vogel, Jai Karan, Nathan C. Crouther, Marc B. Taub
  • Patent number: 10010273
    Abstract: Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: July 3, 2018
    Assignee: Abbott Diabetes Care, Inc.
    Inventors: Mark K. Sloan, Frederic Arbogast, Jean-Pierre Cole, Namvar Kiaie, Jonathan Fern, Lynne K. Lyons, William Matievich, Jr., Lynn Dixon, Mark P. Jesser, Matthew T. Vogel, Jai Karan, Nathan C. Crouther, Marc B. Taub
  • Publication number: 20170007762
    Abstract: Medical data provided by a physiological parameter sensor is used for management of the patient's medical condition. Analytes that may be monitored and managed include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, glucose, glutamine, growth hormones, hormones, ketones, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, thyroid stimulating hormone, and troponin.
    Type: Application
    Filed: September 23, 2016
    Publication date: January 12, 2017
    Inventors: Gary A. Hayter, John C. Mazza, Jai Karan, Saeed Nekoomaram
  • Patent number: 9532737
    Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: January 3, 2017
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jai Karan, Annie Tan, Marc B. Taub, Timothy C. Dunn, Joel Goldsmith, Christine M. Neuhaus, Stephen A. Rossi
  • Publication number: 20160331287
    Abstract: Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.
    Type: Application
    Filed: May 16, 2016
    Publication date: November 17, 2016
    Inventors: Jonathan Fern, Mark P. Jesser, Lynn Dixon, Jai Karan, Charles Wei, Matthew T. Vogel, Timothy S. Gasperak, Kim Cullen, Kim Ladin, Marc B. Taub, Gary A. Hayter
  • Publication number: 20160203275
    Abstract: A system for generating a report having varying integrated levels of medical information related to a health condition is provided. The system comprises a host server having a host database and a client component that connects to the host server. The client component includes a report software application that is configured to generate a report and provide a GUI on the display. A processor populates the GUI based upon received and processed medical information from the host server component and arranges the medical information in predetermined, interrelated levels. A cursor is provided to allow the user to point to an area of interest in the display and a further level of information pertaining to one or more layers of medical information is viewable by a user when the cursor is pointed over an image on the display.
    Type: Application
    Filed: November 11, 2015
    Publication date: July 14, 2016
    Inventors: Drinda Benjamin, Charles Wei, Jai Karan, Gary A. Hayter
  • Patent number: 9339219
    Abstract: Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: May 17, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Jonathan Fern, Mark P. Jesser, Lynn Dixon, Jai Karan, Charles Wei, Matthew T. Vogel, Timothy S. Gasperak, Kim Cullen, Kim Ladin, Marc B. Taub, Gary A. Hayter
  • Publication number: 20160081598
    Abstract: Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.
    Type: Application
    Filed: November 30, 2015
    Publication date: March 24, 2016
    Inventors: Jonathan Fern, Mark P. Jesser, Lynn Dixon, Jai Karan, Charles Wei, Matthew T. Vogel, Timothy S. Gasperak, Kim Cullen, Kim Ladin, Marc B. Taub, Gary A. Hayter
  • Patent number: 9198623
    Abstract: Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: December 1, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Jonathan Fern, Mark P. Jesser, Lynn Dixon, Jai Karan, Charles Wei, Matthew T. Vogel, Tim S. Gasperak, Kim Cullen, Kim Ladin, Marc B. Taub, Gary A. Hayter